Skip to main content

Table 5 Main outcomes in different types of cancer

From: Clinical characteristics, outcomes, and risk factors for mortality in hospitalized patients with COVID-19 and cancer history: a propensity score-matched study

Cancer types Total
N = 53 (%)b
Dead
N = 27 (%)c
ICU Admission
N = 29(%)d
Intubation
N = 27 (%)e
Hospital stay; days
Median (IQR)
Solid tumors 29 (54.7) 10 (37) 11 (37.9) 10 (37) 6 (2;10)
 Gastrointestinal 14 (26.4) 5 (18.5) 6 (20.7) 5 (18.5) 5.5 (2;11)
 Breast 4 (7.6) 2 (7.4) 2 (6.9) 2 (7.4) 5 (2.5;7.5)
 Lung 5 (9.4) 0 0 0 7 (6;13)
 Genitourinary 5 (9.4) 2 (7.4) 2 (6.9) 2 (7.4) 8 (2;17)
 Laryngeal 1 (1.9) 1 (3.7) 1 (3.5) 1 (3.7) 1
Hematologic cancers 24 (45.28) 17 (63) a 18 (62.1) 17 (63) 6.5 (2;14)
 ALL 3 (5.66) 2 (7.4) 2 (6.9) 2 (7.4) 7 (1;21)
 AML 9 (16.98) 5 (18.5) 5 (17.2) 5 (18.5) 6 (2;13)
 CLL 4 (7.55) 4 (14.8) 4 (13.8) 4 (14.8) 4 (1.5;15.5)
 CML 1 (1.89) 1 (3.7) 1 (3.5) 1 (3.7) 10
 Lymphoma 5 (9.43) 4 (14.8) 4 (13.8) 4 (14.8) 9 (8;15)
 MM 2 (3.77) 1 (3.7) 2 (6.9) 1 (3.7) 5 (1;9)
  1. ALL Acute lymphoblastic leukemia, AML Acute myeloid leukemia, CLL Chronic lymphocytic leukemia, CML Chronic myelogenous leukemia, MM Multiple myeloma
  2. a Mortality was significantly higher in hematologic cancer patients than patients with solid tumor (P value = 0.013)
  3. bPercentage in 53 cancer patients
  4. cPercentage in 27 non-survived cancer patients
  5. dPercentage in 29 ICU admitted cancer patients
  6. ePercentage in 27 intubated cancer patients